LAS VEGAS, Aug. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce it has exclusively licensed a patent application entitled “Structure Based Drug Design of Steroid Inhibitors” from Georgetown University.
